Mark Duncan, MD

Personal Statement

I practice adult general psychiatry at the UW Outpatient Psychiatry Clinic. In addition, I am a specialist in addiction psychiatry offering both consultation and ongoing care for substance use disorders. I also provide ongoing psychiatric consultation for primary care clinics across the Puget Sound region through the UW Division of Population Health, which is a special interest of mine. Additionally, I am a study physician in the NIH-funded Harm Reduction with Pharmacotherapy study, testing extended release naltrexone and harm reduction counseling to reduce alcohol-related harm and improve quality of life among homeless individuals with alcohol dependence. I am board-certified in both family medicine, general psychiatry, addiction psychiatry, although I am not currently practicing family medicine.


Rush University Medical education, 2006
West Suburban Medical Center Residency, Family Medicine
UWMC - Pharmacy Oncology Residency Fellowship, Addiction Psychiatry
University of Washington - School of Medicine Residency, Psychiatry

Department Affiliations

Substance use treatment integration in primary care settings; substance use in underserved populations.​

Recent Publications

Vale Al Yergey.
(2020 Aug)
J Mass Spectrom 55(8): e4535
Duncan MW, Gale PJ

Foreword to a general approach to calculating isotopic distributions for mass spectrometry.
(2020 Aug)
J Mass Spectrom 55(8): e4537
Duncan MW

Response Regarding: Is Prophylactic Total Gastrectomy Always Indicated in CDH1 Germline Mutant Carriers?
(2020 Nov)
J Surg Res 255(): 649-650
Duncan MD

Tools for quantitative analysis: The Al Yergey perspective.
(2020 Aug)
J Mass Spectrom 55(8): e4524
Gale PJ, Duncan MW

Quantitative Assays of Plasma Apolipoproteins.
Methods Mol Biol 2138(): 49-81
Poljak A, Duncan MW, Jayasena T, Sachdev PS

Show complete publication list »